𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugatedL-asparaginase in patients with advanced solid tumors

✍ Scribed by Charles W. Taylor; Robert T. Dorr; Paul Fanta; Evan M. Hersh; Sydney E. Salmon

Publisher
Springer
Year
2000
Tongue
English
Weight
101 KB
Volume
47
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I evaluation of docetaxel and topo
Phase I evaluation of docetaxel and topotecan for patients with advanced solid tumors
✍ Anne S. Tsao; Dong M. Shin; J. Lynn Palmer; Jin S. Lee; Bonnie S. Glisson 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

## Abstract ## BACKGROUND The authors administered a combination of docetaxel and topotecan with granulocyte–colony‐stimulating factor (G‐CSF) support in a Phase I study to define the maximum tolerated dose (MTD) of this regimen. ## METHODS Patients with advanced‐stage solid tumors were eligible

A Phase I–II trial of polyethylene glyco
A Phase I–II trial of polyethylene glycol-conjugated L-asparaginase in patients with multiple myeloma
✍ Neeraj R. Agrawal; Ronald M. Bukowski; Lisa A. Rybicki; Joanne Kurtzberg; Lewis 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

## Abstract ## BACKGROUND Multiple myeloma remains an incurable disease. New agents are needed to improve therapy for patients with this disease. Previous investigators evaluated in vitro sensitivity of myeloma cells to polyethylene glycol‐conjugated L‐asparaginase (PEG‐L‐asparaginase) using the h